Table 1.
Demographic and clinical information of the study cohort.
HV | CHR | FEP | P-valuea | |
---|---|---|---|---|
N | 40 | 47 | 103 | |
Age, years (mean ± SD [min, max]) | 28.6 ± 8.9 [18, 58] | 23.3 ± 4.6 [17, 35] | 29.5 ± 9.3 [16, 69] | ≤0.001 |
Gender (male/female) | 25/15 | 38/9 | 58/45 | 0.012 |
Ethnicityb | 39/1/0/0 | 47/0/0/0 | 96/3/3/1 | 0.550 |
Educationc (≥13 years/ <13 years/unknown) | 32/6/2 | 24/23/0 | 43/51/9 | ≤0.001 |
Antipsychotic medication (%) | 0 | 0 | 0 | |
PANSS total (median [min, 25th, 75th, max], n) | – | 70 [36, 55.75, 83.25, 104], 38 | 93 [45, 75.5, 107.5, 143], 97 | – |
PANSS positive (median [min, 25th, 75th, max], n) | – | 15.5 [8, 12, 18, 24], 38 | 21 [10, 18, 26.5, 38], 97 | – |
PANSS negative (median [min, 25th, 75th, max], n) | – | 17.5 [7, 11, 21, 32], 38 | 24 [9, 17, 29, 40], 97 | – |
PANSS general (median [min, 25th, 75th, max], n) | – | 36 [21, 29, 44, 54], 38 | 48 [24, 38.5, 54, 73], 97 | – |
ANOVA or Fisher's Exact Test.
Caucasian/African/Asian/Other.
percentage that completed at least 13 years, a high-school diploma equivalent.